Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ARMPthis companyArmata Pharmaceuticals, Inc.	$3.36	-1.31×	-1.04×	46.41×	-3.26×	-475.8%	68.8%	-636.7%	-3544.0%	79.5%	-43.1%	-11.6%	-1.32×	-1.79×	-1.88×	1.19×	0.0%	2	-17.44	2	C
SPROSpero Therapeutics, Inc.	$1.05	15.53×	2.21×	2.19×	10.55×	-2700.7%	100.0%	-0.0%	14.4%	14.5%	-0.0%	-9.7%	0.05×	-4.23×	0×	7.59×	0.0%	6	-5.89	4	A-
Peer median	—	15.53×	2.21×	2.19×	10.55×	-2700.7%	100.0%	-0.0%	14.4%	14.5%	-0.0%	-9.7%	0.05×	-4.23×	0×	7.59×	0.0%	6	-5.89	4	—